BOCA RATON, Fla.--(BUSINESS WIRE)--Jun. 6, 2016-- TherapeuticsMD, Inc. (NYSE MKT:TXMD) an innovative women’s healthcare company and parent company of vitaMedMD^®, LLC (“vitaMedMD”) and BocaGreenMD^®, Inc. (“BocaGreenMD”), announced today an exciting new advancement in compliance packaging for prenatal vitamins that contain iron.

This innovative packaging provides a much-needed solution to the challenges faced in effectively creating – and using – child-resistant safety packaging for prenatal vitamins that contain iron. It features a unique blister pack locking system, designed for adults to easily open by squeezing the sides, pulling out the pill blister, and pressing the capsule through the foil backing.

Jason Spitz, TherapeuticsMD’s Vice President of Marketing, said, “As a leader in healthcare solutions for women, we are continually looking for ways to provide patients with products that embody efficacy, safety, and convenience. In talking with our customers, we found they have generally experienced frustration trying to open currently available child-resistant packages.”

He added, “Our exciting new packaging addresses a longtime need in the prenatal market to offer women more convenient blister packaging for each dose, while also meeting important safety needs. It reflects our commitment to women’s health, strengthens our relationships with Ob/Gyns, and helps to grow trust in our unique products for women.”

The company is launching this packaging for vitaMedMD’s vitaPearl™ prenatal multivitamin and BocaGreen’s Prena1 Pearl, the brand’s authorized generic. vitaPearl and Prena1 Pearl contain more folic acid than the leading prescription prenatal vitamin, providing 16 vitamins and minerals, plus 200 mg of pur-DHA™, a highly-purified, marine-based DHA. Both feature 1.4 mg of FOLMAX^®, a proprietary immediate and modified release folic acid formulated to help maintain folate levels in a woman’s body throughout the day, and 30 mg of FePlus^®, a chelate-containing iron that is readily absorbed and easy on the stomach.

vitaPearl and Prena1 Pearl are gluten-free, lactose-free, and sugar-free, and are available by prescription through retail and mail order pharmacies nationwide.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA^™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD^® and BocaGreenMD^® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com and www.bocagreenmd.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160606005328/en/

Source: TherapeuticsMD, Inc.

Investors
TherapeuticsMD, Inc.
David DeLucia, 561-961-1900
Director, Investor Relations
David.Delucia@TherapeuticsMD.com
or
Media (WCG)
Elliot Fox, 212-257-6724
Director, Media & Engagement
efox@w2ogroup.com